Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,010,368 | 5,308,496 | 5,300,941 | 5,381,930 | 5,171,015 |
| Marketable Securities | 638,450 | 744,792 | 379,282 | 293,063 | 363,066 |
| Receivables | 9,530,781 | 10,286,520 | 9,078,328 | 8,750,195 | 8,879,089 |
| Inventories | 7,593,724 | 8,355,485 | 7,661,486 | 7,395,595 | 7,309,365 |
| Other current assets | 1,114,737 | 1,187,477 | 1,015,704 | 1,004,228 | 871,625 |
| TOTAL | $24,888,060 | $25,882,770 | $23,435,740 | $22,825,010 | $22,594,160 |
| Non-Current Assets | |||||
| PPE Net | 13,213,360 | 13,154,710 | 13,351,990 | 13,377,980 | 14,760,220 |
| Investments And Advances | 2,878,133 | 2,573,480 | 2,282,117 | 2,274,165 | 2,171,719 |
| Intangibles | 53,013,060 | 53,641,080 | 34,919,608 | 34,944,767 | 30,688,387 |
| Other Non-Current Assets | 7,766,107 | 7,397,370 | 7,822,205 | 7,808,488 | 7,292,014 |
| TOTAL | $76,870,660 | $76,766,640 | $58,375,920 | $58,405,400 | $54,912,340 |
| Total Assets | $101,758,700 | $102,649,400 | $81,811,660 | $81,230,410 | $77,506,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,833,594 | 10,131,150 | 13,046,000 | 10,957,930 | 7,732,497 |
| Accounts payable and accrued liabilities | 19,075,610 | 18,172,200 | 17,209,090 | 17,484,760 | 18,736,590 |
| Accrued Expenses | 803,170 | 752,191 | 645,421 | 1,256,912 | 1,288,082 |
| Other current liabilities | 1,997,072 | 2,405,778 | 2,243,546 | 2,159,545 | 2,263,821 |
| TOTAL | $30,709,450 | $31,461,310 | $33,144,060 | $31,859,150 | $30,020,990 |
| Non-Current Liabilities | |||||
| Long Term Debt | 30,122,070 | 30,621,570 | 29,973,520 | 30,405,560 | 27,057,730 |
| Other Non-Current Liabilities | 12,341,328 | 13,268,148 | 13,183,572 | 12,853,076 | 13,994,172 |
| TOTAL | $47,609,210 | $48,918,300 | $44,852,930 | $44,980,540 | $42,584,120 |
| Total Liabilities | $78,318,660 | $80,379,630 | $77,996,990 | $76,839,690 | $72,605,110 |
| Shareholders' Equity | |||||
| Common Shares | 1,718,707 | 1,658,520 | 1,729,266 | 1,751,863 | 1,795,306 |
| Retained earnings | 5,784,357 | 6,492,271 | -3,605,103 | -3,175,495 | -2,852,468 |
| Other shareholders' equity | 11,884,105 | 10,216,238 | 1,631,554 | 1,710,182 | 1,832,681 |
| TOTAL | $23,440,050 | $22,269,790 | $3,814,672 | $4,390,728 | $4,901,386 |
| Total Liabilities And Equity | $101,758,710 | $102,649,420 | $81,811,662 | $81,230,418 | $77,506,496 |